JI
Sen. James Inhofe (R-OK) sold $15K-$50K of NTLA stock
James Inhofe, U.S. Senator (R-OK), disclosed a sale of Intellia Therapeutics, Inc. (NTLA) stock worth $15K-$50K in a STOCK Act filing on Nov 8, 2018.
The trade happened on Oct 25, 2018, 14 days before it was made public.
NTLA has moved -43.0% since the trade date, from $20.00 to $11.41 (Nov 11, 2026 close).
- Traded
- Oct 25, 2018
- Disclosed
- Nov 8, 2018
- Filing delay
- 14 days
- Price since
- -43.0%
- Source
- STOCK Act disclosure